Hicks Derek
- SEC CIK
- 0001901282
No open-market purchases or sales filed in the past year.
Current role at each company
- NTLA Intellia Therapeutics, Inc.EVP, Chief Business Officeras of Jan 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hicks Derek as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Hicks DerekEVP, Chief Business Officer | SSale | −6.50K | $12.18 | −$79.2K | −9.8%59.9K after | |
| Jan 5, 2024 (view filing) | Jan 3 | 2 days | Hicks DerekEVP, Chief Business Officer | SSale | −3.88K | $29.46 | −$114.2K | −9.5%37.0K after | |
| Jan 6, 2023 (view filing) | Jan 4 | 2 days | Hicks DerekEVP, Chief Business Officer | SSale | −1.81K | $37.21 | −$67.4K | −9.5%17.3K after |